Evidence map›Paper›PMID 42304367›Full record

ArticleJournal of translational medicine2026

Single-cell and spatial transcriptomes reveal oligodendrocyte remodeling fatty acid metabolism microenvironment of lung cancer brain metastases.

Yuechao Yang, Yang Gao, Zhe Qi, Sen Li, Zhisu Wang, Deheng Li, Lei Chen, Changshuai Zhou, Mingtao Feng, Xin Chen and 4 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yuechao Yang *Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Yang Gao *Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Zhe Qi *Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Sen LiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Zhisu WangDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Deheng LiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Lei ChenDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Changshuai ZhouDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Mingtao FengDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Xin ChenDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Bin HaoDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Xiaojun WuDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. vincentneuro@163.com.
Liangdong Li *Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. liangdong_li@fudan.edu.cn.
Yiqun CaoDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. yiqun_fduscc@163.com.

Funding

National Natural Science Foundation of China No. 8247295
6 · The paper itself

Abstract

backgroundBrain metastases represent a prevalent and lethal complication in advanced lung cancer, where the brain microenvironment is pivotal in facilitating metastatic tumor progression. Recent findings indicate the presence of oligodendrocyte infiltration within lung cancer brain metastases (LCBM). Lipid metabolic reprogramming has emerged as a critical feature of the brain metastatic niche, influencing both tumor cell survival and immune cell function. This study aimed to determine whether oligodendrocytes undergo lipid metabolic reprogramming in LCBM and whether their derived fatty acids functionally promote tumor proliferation and immune modulation.

methodsSingle cell RNA sequencing (ScRNA-seq), spatial transcriptome sequencing, lipidomics, and lipid tracing techniques to comprehensively analyze metabolic alterations in oligodendrocytes and their dynamic interactions with tumor and immune cells. Western blotting, qPCR and multiple immunofluorescence staining were used to detect the expression of fatty acid synthesis enzymes in oligodendrocytes and immunosuppressive markers in macrophages.

resultsAnalysis of independent scRNA-seq datasets revealed markedly increased lipid synthesis activity in oligodendrocytes within LCBM. Hypoxic conditions and co-culture with metastatic lung cancer cells further enhanced the expression of fatty acid synthases in oligodendrocytes. Spatial transcriptomics and scRNA-seq indicated that tumor cells and macrophages were major recipients of oligodendrocyte-derived fatty acids, exhibiting enhanced uptake and degradation. Treatment with oligodendrocyte-conditioned medium significantly increased the expression of fatty acid uptake proteins in tumor cells and macrophages. Furthermore, oligodendrocyte-derived fatty acids supported tumor cell proliferation and polarized macrophages toward an immunosuppressive phenotype. Notably, scRNA-seq identified a macrophage subpopulation (Mac_FABP4) as a candidate mediator of lipid-driven immune suppression.

conclusionThese findings delineate the pivotal role of oligodendrocytes in LCBM, revealing their contribution of lipids that enhance tumor proliferation and induce immunosuppression, thereby suggesting that glial lipid metabolism may represent a potential therapeutic target warranting further investigation.

Indexed as

Brain NeoplasmsFatty AcidsLung NeoplasmsOligodendrogliaSingle-Cell AnalysisTumor MicroenvironmentAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansLipid MetabolismMacrophagesMetabolic ReprogrammingSpatial TranscriptomicsFatty AcidsFatty acid metabolismMacrophageOligodendrocytesTumor microenvironment

Identifiers

PMID42304367
PMCPMC13520405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.